ALERT. A NEW TREATMENT HAS BEEN APPROVED FOR PATIENTS WITH TYPE ONE DIABETES THE U.S. FOOD AND DRUG ADMINISTRATION HAS GIVEN THE GO AHEAD TO THE FIRST EVER CELLULAR THERAPY FOR ADULTS WHO HAVE TROUBLE MANAGING THEIR BLOOD GLUCOSE LEVELS. OUR CHIEF HEALTH EDITOR, DOCTOR PARTON AND HERE WITH MORE DETAILS ON THIS GROUNDBREAKING TREATMENT. DOCTOR. YEAH, I'M EXCITED, RIGHT? SO GREAT NEWS FOR NEARLY 2 MILLION FOLKS IN THE U.S. WHO HAVE TYPE ONE DIABETES, NOT SOCRATIC, CHRONIC AUTOIMMUNE CONDITION. WHEN THE WHEN THE PANCREAS PRODUCES LITTLE OR NO INSULIN PATIENTS BUS LIFELONG CARE, WHICH INCLUDES DAILY INJECTIONS OR INFUSIONS OF INSULIN. >> THE FDA HAS GIVEN THE GREEN CALLED LAND TO DROUGHT TO HELP ADULTS WITH TYPE ONE DIABETES MEAN TEAM THAT TARGET BLOOD GLUCOSE LEVELS. NOW, WHAT HAPPENS ALL PATIENTS OFTEN SUFFER FROM REPEATED EPISODES OF SEVERE HYPOGLYCEMIA OR LOW BLOOD SUGAR BECAUSE THEY HAVE DIFFICULTY MANAGING THE RIGHT DOSE OF INSULIN AND SOMETIMES THESE FOLKS DEVELOP WHAT'S CALLED HYPOGLYCEMIA AN AWARENESS, WHICH MEANS THEY'RE UNABLE TO DETECT WHEN THEIR BLOOD GLUCOSE IS DROPPING. DON'T KNOW AND WITHOUT TREATMENT, RISK LOSING CONSCIOUSNESS OR EVEN HAVING SEIZURES. SO HERE'S HOW LAND TO DRILL HELP. FIRST OF ALL, THIS THERAPY IS MADE FROM DECEASED DONOR PANCREATIC CELLS AND WHAT IT AIMS TO DO IS REPLACE THE INSULIN, PRODUCING BETA CELLS IN THE PANCREAS. AFTER THE INITIAL INFUSIONS, THESE CELLS WITH NC CREATE MAKE INSULIN INTO THE BODY AND IN SOME CASES, THESE CELLS COULD PRODUCE ENOUGH INSULIN THAT THERE'S NO LONGER A NEED FOR THE PATIENT INJECTOR PUMP INSULIN IN ORDER TO CONTROL THEIR BLOOD SUGAR LEVEL. SO VERY, VERY EXCITING. SO DOES THIS NEW CELL THERAPY HAVE TO BE REPEATED IN ORDER TO BE EFFECTIVE? AND WHAT ABOUT THE SIDE EFFECTS? ALL WAS SIDE EFFECTS RIGHT TO FIRST THE LAB TO DRUGS, GIVEN TO A PATIENT AS A SINGLE INFUSION BLEND INTO THE PORTAL VEIN AND THAT'S THE BLOOD VESSEL THAT DELIVERS BLOOD A RIGHT TO THE LIVER AND ADDITIONAL INFUSION CAN BE DEPENDING ON THE PATIENTS RESPOND TO THE FIRST DOSE DURING THE 2 CLINICAL STUDIES, 30 PARTICIPANTS, 30 FOLKS WITH TYPE ONE DIABETES, HYPOGLYCEMIC AWARENESS RECEIVED BETWEEN ONE AND 3 INFUSIONS OF LINE TO DRAW AFTERWARD. 11 OF DID NOT NEED INSULIN FOR ONE TO 5 YEARS. SUPER EXCITING AND 10 OF THEM DID NOT HAVE TO TAKE INSULIN FOR MORE THAN 5 YEARS. ONLY 5 OF THE PATIENTS WERE NOT ABLE TO GET RID OF THEIR INSULIN, DEPENDENT FOR ANY LENGTH OF TIME. SO THE SIDE EFFECTS NOT WRITE THIS VARIED, DEPENDING ON THE NUMBER OF INFUSE THE PATIENTS RECEIVED AND THE LENGTH OF TIME THEY WERE FOLLOWED IN THE STUDY, THE MOST COMMON NAUSEA, FATIGUE, ANEMIA, AND ABDOMINAL PAIN. HOWEVER, A MAJORITY OF THE PARTICIPANTS DID EXPERIENCE AT LEAST ONE SERIOUS ADVERSE REACTION TO THE PROCEDURE FOR INFUSING LEAD TO DRAW INTO THE BODY AND THE USE OF IMMUNOSUPPRESSIVE MEDICATIONS DID BUCK IMMUNE SYSTEM TO HELP THE DONOR SOLVE REMAIN VIABLE AND LIVE IN THE BODY. SO WHILE THIS IS A MAJOR BREAKTHROUGH FOR TYPE ONE DIABETES, IMPORTANT FOR PATIENTS TO DISCUSS BENEFITS VERSUS RISKS. BUT I'LL TELL YOU IT. THIS IS VERY, VERY IMPORTANT. I THINK IT'S A GREAT BREAKTHROUGH. ANYTHING THAT THAT HELPS PATIENTS WITH DIABETES. LISTEN, THAT THAT DISEASE KILLED MY MOM'S ANYTHING THAT COULD HELP. THAT DISEASE WILL BE GREAT. SO SORRY, DOT THANK YOU FOR SHARING WITH, OF COURSE, AND BE SURE TO TUNE IN THIS WEEKEND TO THE DOCTOR. NANDY SHOW HE'S DISCUSSING RACIAL DISCRIMINATION AND THE THOUSANDS OF HATE CRIMES THAT HAPPEN EVERY YEAR IN OUR COUNTRY. HE'LL BE SITTING DOWN. >> WITH A PANEL OF ACTIVISTS TO TALK ABOUT HOW WE MOVE FROM A TOLERANCE TO INCLUSION.
